Skip to main content

Mª Pilar Felipe Fernandez

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Mª Pilar Felipe Fernandez

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

The annual event offered a space for dialogue between the scientific community and society on how to address the future of ageing through research and innovation.

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Related professionals

Monica Higuera Urbano

Monica Higuera Urbano

Research technician
Liver Diseases
Read more
Ariadna Campos Martorell

Ariadna Campos Martorell

Growth and Development
Read more
Mayli Lung Suarez

Mayli Lung Suarez

Microbiology
Read more
Josep Sanjose Puig

Josep Sanjose Puig

Tècnic/a Superior Recerca
Clinical Research Development Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.